1 terminated. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
Follow Current Smoker: new trials by email Literature Review of Current Smoker trials Research Report on Current Smoker
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Bupropion Hydrochloride, Laboratory Biomarker Analysis, Nicotine Replacement - Current Smoker, Head and Neck Squamous Cell Carcinoma | Early Phase 1 | Terminated | Wake Forest University Health Sciences | 9 | 2016-01-01 | 2023-03-22 |
Nasopharyngeal Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1) · Pharyngeal Diseases (1) · Pharyngeal Neoplasms (1) · Stomatognathic Diseases (1)
Bupropion (1) · Nicotine Replacement Therapy (1) · Varenicline (1)
Wake Forest University Health Sciences (1)
United States (1)
P30CA012197 (1)